Powered by

Axios Pro Rata

Aug 26, 2020 - Axios.com

Freenome , a South San Francisco-based developer of early colorectal cancer testing via blood draw, raised $270 million in Series C funding. Bain Capital Life Sciences and Perceptive Advisors co-led, and were joined by Fidelity, Janus Henderson, Farallon Capital Management, Rock Springs Capital, Cormorant Asset Management, EcoR1, Catalio Capital, the Colorectal Cancer Alliance and return backers RA Capital Management, T. Rowe Price, BrightEdge Ventures, Sands Capital, Andreessen Horowitz, DCVC, ...